The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 randomized study of magrolimab combination therapy in adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): ELEVATE-TNBC.
 
Natalie Rainey
Consulting or Advisory Role - Lilly; MSD Oncology
Other Relationship - MSD Oncology; Pfizer
 
Rohit Joshi
Honoraria - AstraZeneca; Gilead Sciences; MSD
Consulting or Advisory Role - Novartis
 
Joanne Chiu
Honoraria - AstraZeneca; Lilly
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Ann Chen
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Hao Wang
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Jared Odegard
Employment - Gilead Sciences; Silverback Therapeutics (I)
Leadership - Abata Therapeutics (I); Odyssey Therapeutics (I); Silverback Therapeutics (I)
Stock and Other Ownership Interests - Abata Therapeutics (I); Gilead Sciences; Odyssey Therapeutics (I); Silverback Therapeutics (I)
 
Estibaliz Lopez Rodrigo
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Sylvia Adams
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst)